News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
816,970 Results
Type
Article (75623)
Company Profile (643)
Press Release (740704)
Section
Business (227833)
Career Advice (3774)
Deals (39175)
Drug Delivery (128)
Drug Development (89250)
Employer Resources (198)
FDA (17814)
Job Trends (17101)
News (387881)
Policy (38747)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (12)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (7)
2025 BioForest Digital (6)
2025 Lone Star Bio Digital (9)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2992)
Academic (2)
Accelerated approval (5)
Adcomms (29)
Allergies (88)
Alliances (56071)
ALS (93)
Alzheimer's disease (1479)
Antibody-drug conjugate (ADC) (141)
Approvals (17782)
Artificial intelligence (278)
Autoimmune disease (22)
Automation (14)
Bankruptcy (401)
Best Places to Work (12632)
BIOSECURE Act (21)
Biosimilars (115)
Biotechnology (440)
Bladder cancer (65)
Brain cancer (30)
Breast cancer (274)
Cancer (2174)
Cardiovascular disease (189)
Career advice (3212)
Career pathing (33)
CAR-T (161)
Cell therapy (456)
Cervical cancer (21)
Clinical research (71843)
Collaboration (842)
Compensation (482)
Complete response letters (30)
COVID-19 (2858)
CRISPR (43)
C-suite (232)
Cystic fibrosis (105)
Data (2038)
Decentralized trials (2)
Denatured (42)
Depression (50)
Diabetes (275)
Diagnostics (6883)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (126)
Drug pricing (122)
Drug shortages (33)
Duchenne muscular dystrophy (93)
Earnings (93670)
Editorial (39)
Employer branding (25)
Employer resources (167)
Events (128265)
Executive appointments (692)
FDA (19003)
Featured Employer (64)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (747)
Gene editing (111)
Generative AI (28)
Gene therapy (326)
GLP-1 (822)
Government (5089)
Grass and pollen (5)
Guidances (49)
Healthcare (20866)
Huntington's disease (24)
IgA nephropathy (28)
Immunology and inflammation (129)
Indications (27)
Infectious disease (3007)
Inflammatory bowel disease (148)
Inflation Reduction Act (11)
Influenza (53)
Intellectual property (91)
Interviews (741)
IPO (17689)
IRA (51)
Job creations (4969)
Job search strategy (2627)
Kidney cancer (10)
Labor market (38)
Layoffs (539)
Leadership (20)
Legal (9909)
Liver cancer (76)
Lung cancer (317)
Lymphoma (139)
Machine learning (4)
Management (65)
Manufacturing (305)
MASH (68)
Medical device (14565)
Medtech (14570)
Mergers & acquisitions (21964)
Metabolic disorders (730)
Multiple sclerosis (79)
NASH (23)
Neurodegenerative disease (104)
Neuropsychiatric disorders (31)
Neuroscience (2026)
NextGen: Class of 2025 (7636)
Non-profit (5077)
Northern California (2520)
Now hiring (38)
Obesity (397)
Opinion (270)
Ovarian cancer (75)
Pain (90)
Pancreatic cancer (79)
Parkinson's disease (148)
Partnered (21)
Patents (221)
Patient recruitment (101)
Peanut (51)
People (63925)
Pharmaceutical (132)
Pharmacy benefit managers (21)
Phase I (22182)
Phase II (31320)
Phase III (23640)
Pipeline (1107)
Podcasts (120)
Policy (140)
Postmarket research (3280)
Preclinical (9790)
Press Release (72)
Prostate cancer (99)
Psychedelics (38)
Radiopharmaceuticals (267)
Rare diseases (406)
Real estate (7150)
Recruiting (75)
Regulatory (25923)
Reports (57)
Research institute (2653)
Resumes & cover letters (589)
Rett syndrome (4)
RNA editing (4)
RSV (47)
Schizophrenia (76)
Series A (133)
Series B (84)
Service/supplier (26)
Sickle cell disease (57)
Southern California (2190)
Special edition (18)
Spinal muscular atrophy (165)
Sponsored (33)
Startups (4187)
State (2)
Stomach cancer (16)
Supply chain (67)
Tariffs (14)
The Weekly (76)
United States (22800)
Vaccines (774)
Venture capitalists (39)
Webinars (13)
Weight loss (291)
Women's health (37)
Worklife (19)
Date
Today (109)
Last 7 days (709)
Last 30 days (2824)
Last 365 days (36146)
2025 (8929)
2024 (37916)
2023 (42567)
2022 (53927)
2021 (58722)
2020 (57665)
2019 (51316)
2018 (39098)
2017 (36856)
2016 (37795)
2015 (43818)
2014 (38554)
2013 (34691)
2012 (36538)
2011 (36589)
2010 (36122)
Location
Africa (1199)
Alabama (56)
Alaska (7)
Arizona (240)
Arkansas (14)
Asia (48374)
Australia (8327)
California (5862)
Canada (1921)
China (511)
Colorado (264)
Connecticut (281)
Delaware (137)
Europe (109954)
Florida (854)
Georgia (209)
Hawaii (1)
Idaho (63)
Illinois (578)
India (28)
Indiana (316)
Iowa (10)
Japan (147)
Kansas (107)
Kentucky (27)
Louisiana (12)
Maine (69)
Maryland (907)
Massachusetts (4546)
Michigan (234)
Minnesota (399)
Mississippi (2)
Missouri (87)
Montana (31)
Nebraska (26)
Nevada (58)
New Hampshire (69)
New Jersey (1678)
New Mexico (31)
New York (1673)
North Carolina (1072)
North Dakota (8)
Northern California (2520)
Ohio (207)
Oklahoma (15)
Oregon (45)
Pennsylvania (1302)
Puerto Rico (10)
Rhode Island (30)
South America (1569)
South Carolina (19)
South Dakota (1)
Southern California (2190)
Tennessee (98)
Texas (881)
Utah (175)
Virginia (152)
Washington D.C. (65)
Washington State (561)
West Virginia (3)
Wisconsin (61)
816,970 Results for "procter and gamble co".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Zealand Pharma and Roche enter collaboration and license agreement to co-develop and co-commercialize petrelintide as a future foundational therapy for people with overweight and obesity
March 12, 2025
·
13 min read
Press Releases
Top Neuroscientist Matthew Anderson Appointed Co-Director of the Oxford-Harrington Rare Disease Centre
February 19, 2025
·
3 min read
Press Releases
Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results
March 28, 2025
·
10 min read
Press Releases
Roche enters into an exclusive collaboration & licensing agreement with Zealand Pharma to co-develop and co-commercialise petrelintide as a potential foundational therapy for people with overweight and obesity
March 12, 2025
·
9 min read
Career Advice
How to Deal With a Toxic Co-Worker
Dealing with a toxic co-worker can be exhausting, and it can make your workplace more stressful. There are a few ways to make it easier, including developing healthy coping mechanisms and even talking it out with your colleague.
September 25, 2024
·
5 min read
·
Alina Zahid
Press Releases
EG 427 raises €27 million in successful Series B co-led by Andera Partners and Bpifrance to finance on-going clinical study and platform development
February 20, 2025
·
6 min read
Press Releases
Marvel Presenting at the 2025 Bloom Burton & Co. Conference
March 11, 2025
·
4 min read
Press Releases
Pierre Fabre Laboratories and RedRidge Bio Announce a Drug Discovery and Co-development Partnership
March 12, 2025
·
2 min read
Press Releases
Orbus Therapeutics Appoints Jason Levin, Co-founder and COO to President
February 27, 2025
·
3 min read
Rare diseases
Biogen and Stoke Strike Dravet Syndrome Co-Development Deal
The partnership splits the rights to Stoke’s epilepsy antisense oligonucleotide, with up to $385 million in potential payments due to Stoke.
February 18, 2025
·
2 min read
·
Dan Samorodnitsky
1 of 81,697
Next
